Brevel Introduces Fermentation-Derived Chlorella to Address Supply, Purity Challenges

Biotechnology company Brevel recently launched Purallis, a chlorella ingredient produced through the company’s proprietary illuminated fermentation platform, designed to deliver consistent quality at scale. The ingredient is position to address the longstanding challenges of production and sourcing of chlorella, a March 18 press release from the company explains.¹ The plant-based protein-alternative is able to be formulated in functional foods and beverages in multiple categories including active nutrition and metabolic wellness.

Addressing Cultivation and Production Challenges

Chlorella has long been recognized for its dense nutritional profile, but, as Brevel explains, traditional cultivation methods present limitations. Approximately 90% of global chlorella supply is grown in open freshwater ponds, where exposure to environmental contaminants such as heavy metals, pesticides, and microorganisms can compromise product purity. As a bioaccumulator, chlorella readily absorbs substances from its surroundings, making controlled cultivation and rigorous testing essential for nutraceutical applications.

Brevel’s approach replaces open-pond systems with closed, indoor bioreactors that integrate light into a fermentation-based process. This “illuminated fermentation” platform represents a hybrid production model that combines the high-yield advantages of fermentation with the nutrient-enhancing effects of photosynthesis.

Another technical barrier historically associated with chlorella is its rigid cell wall, composed of indigestible polysaccharides. To address bioavailability concerns, Brevel applies a mechanical bead milling process that breaks down the cell wall without the use of harsh chemicals or high heat, enabling access to the algae’s nutritional components.

Multifunctional Benefits of Chlorella

Chlorella is rich in key micronutrients, including iron, B vitamins, omega-3 fatty acids, and antioxidant compounds such as chlorophyll, carotenoids, and polyphenols. “Our clean-label Purallis chlorella is cultivated in fully controlled, sterile bioreactors, eliminating any risk of contaminants or heavy metals,” explains Yfah Burstin, Chief Business Officer for Brevel. “Thanks to the integrated light, it delivers premium chlorella that is exceptionally rich in complete protein, antioxidants, and chlorophyll. Moreover, the concentrated light extends nutrient density and functionality, while delivering a very mild flavor. For example, it can adjust iron levels for optimized formulations.”

Beyond its nutritional attributes, chlorella is gaining renewed attention for its potential functional benefits. Emerging research suggests roles in metabolic health and gut microbiome modulation. Brevel highlights early findings indicating chlorella may act as a “precision prebiotic,” selectively supporting beneficial gut bacteria.² Additionally, the ingredient may have relevance in reduced-calorie dietary frameworks, such as GLP-1-driven weight management regimens, where nutrient density is critical.

Projected Growth of Chlorella

Market dynamics further support the ingredient’s growth trajectory, Brevel states, citing data from Mordor Intelligence. The global chlorella market, currently valued at approximately $328 million, is projected to approach $486 million in the coming years, driven by consumer interest in sustainable, plant-based nutrition and clean-label formulations.³

Brevel’s industrial-scale production capabilities are central to its commercialization strategy. The company reports that its facilities operate under recognized food safety and quality standards, including HACCP and FSSC 22000, and offer certifications such as non-GMO, kosher, and halal. “Our Industrial-scale operations ensure year-round availability of standardized, high value chlorella, delivering reliable supply and meeting demand at any volume, from pilot to global commercial quantities,” states Yonatan Golan, co-founder and CEO of Brevel.

In February last year, Brevel announced a partnership with the Israeli beverage company, the Central Bottling Company (CBC Group).⁴ The 10-year long term purchase agreement intends to create and commercialize functional beverages and dairy alternatives, with products containing Brevel’s algae-derived proteins and oils.

This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.

References

1. Brevel Ltd. Brevel’s Illuminated Fermentation Brings Pure Chlorella to the Nutraceutical Space. Press release provided via email March 18, 2026. Accessed March 23, 2026.
2. Nishimoto Y, Nomaguchi T, Mori Y, Ito M, Nakamura Y, Fujishima M, et al. The Nutritional Efficacy of Chlorella Supplementation Depends on the Individual Gut Environment: A Randomised Control Study. Front. Nutr. 2021;8:648073. doi: 10.3389/fnut.2021.648073
3. Mordor Intelligence. CHLORELLA INGREDIENTS MARKET SIZE & SHARE ANALYSIS - GROWTH TRENDS AND FORECAST (2026 - 2031). Accessed March 23, 2026. https://www.mordorintelligence.com/industry-reports/chlorella-ingredients-market?utm_source=chatgpt.com
4. McEvoy E. Brevel and The Central Bottling Company form partnership to develop algae-derived functional beverages and dairy alternatives. Published February 6, 2025. Accessed March 23, 2026. https://www.nutritionaloutlook.com/view/brevel-and-the-central-bottling-company-form-partnership-to-develop-algae-derived-functional-beverages-and-dairy-alternatives